Skip to main content

Table 4 Overall survival data for patients stratified according to C30 and HCC18 index score range (n = 472)

From: Prognostic values of EORTC QLQ-C30 and QLQ-HCC18 index-scores in patients with hepatocellular carcinoma – clinical application of health-related quality-of-life data

  N Median OS (M) 95% CI Survival% at 6M Survival% at 12M Survival% at 24M Survival% at 36M
C30 Index Score
 0–20 179 16.4 13.4–22.3 79.7 60.4 41.3 25.6
 21–40 153 7.3 4.5–10.4 52.0 39.2 26.0 21.4
 41–60 98 3.1 2.3–5.1 36.5 27.0 18.3 8.1
 61–80 34 1.8 0.8–4.3 27.5 10.7 7.1 7.1
 81–100 8 1.8 0.5–6.0 25.0 - - -
HCC18 Index Score
 0–20 213 16.4 31.0-NR 74.6 59.9 43.1 27.8
 21–40 169 6.0 4.4–8.9 49.6 33.1 19.3 14.5
 41–60 72 2.8 1.6–4.3 31.1 16.7 11.8 5.3
 61–80 16 1.8 0.5–3.0 25.0 18.8 9.4 -
 81–100 2 1.8 0.7–2.9 - - - -
  1. M month (s), CI, confidence interval, NR not reached